Literature DB >> 16246383

Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.

B V S Krishna1, Asha B Patil, M R Chandrasekhar.   

Abstract

During the cholera epidemic of 2002 in and around Hubli, south India, Vibrio cholerae strains resistant to fluoroquinolones were isolated. Among the isolates of V. cholerae non-O1, non-O139 serogroups, 55.9% and 47.1% were resistant to norfloxacin and ciprofloxacin, respectively. However, only 12.5% of the O1 serogroup strains were resistant to both norfloxacin and ciprofloxacin. Though the O139 serogroup strains were susceptible to these antibiotics, they exhibited multidrug resistance. Emergence of fluoroquinolone-resistant V. cholerae that also exhibited multidrug resistance is of great significance in the epidemiology and control of cholera.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246383     DOI: 10.1016/j.trstmh.2005.07.007

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  11 in total

1.  Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids.

Authors:  Jing-Cao Pan; Rong Ye; Hao-Qiu Wang; Hai-Qing Xiang; Wei Zhang; Xin-Fen Yu; Dong-Mei Meng; Zhe-Sheng He
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

2.  Genomic diversity of 2010 Haitian cholera outbreak strains.

Authors:  Nur A Hasan; Seon Young Choi; Mark Eppinger; Philip W Clark; Arlene Chen; Munirul Alam; Bradd J Haley; Elisa Taviani; Erin Hine; Qi Su; Luke J Tallon; Joseph B Prosper; Keziah Furth; M M Hoq; Huai Li; Claire M Fraser-Liggett; Alejandro Cravioto; Anwar Huq; Jacques Ravel; Thomas A Cebula; Rita R Colwell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

3.  Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India.

Authors:  A K Goel; M Jain; P Kumar; S C Jiang
Journal:  World J Microbiol Biotechnol       Date:  2009-09-18       Impact factor: 3.312

4.  Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010.

Authors:  Huu Dat Tran; Munirul Alam; Nguyen Vu Trung; Nguyen Van Kinh; Hong Ha Nguyen; Van Ca Pham; Mohammad Ansaruzzaman; Shah Manzur Rashed; Nurul A Bhuiyan; Tuyet Trinh Dao; Hubert P Endtz; Heiman F L Wertheim
Journal:  J Med Microbiol       Date:  2011-10-20       Impact factor: 2.472

5.  Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009.

Authors:  Li Yu; Yanyan Zhou; Ruibai Wang; Jing Lou; Lijuan Zhang; Jie Li; Zhenqiang Bi; Biao Kan
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

6.  In Silico Structural and Functional Annotation of Hypothetical Proteins of Vibrio cholerae O139.

Authors:  Md Saiful Islam; Shah Md Shahik; Md Sohel; Noman I A Patwary; Md Anayet Hasan
Journal:  Genomics Inform       Date:  2015-06-30

7.  Genetic traits of Vibrio cholerae O1 Haitian isolates that are absent in contemporary strains from Kolkata, India.

Authors:  Priyanka Ghosh; Arindam Naha; G P Pazhani; T Ramamurthy; Asish K Mukhopadhyay
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

8.  Comparative genome analysis of non-toxigenic non-O1 versus toxigenic O1 Vibrio cholerae.

Authors:  Munmun Mukherjee; Prathusha Kakarla; Sanath Kumar; Esmeralda Gonzalez; Jared T Floyd; Madhuri Inupakutika; Amith Reddy Devireddy; Selena R Tirrell; Merissa Bruns; Guixin He; Ingrid E Lindquist; Anitha Sundararajan; Faye D Schilkey; Joann Mudge; Manuel F Varela
Journal:  Genom Discov       Date:  2014

9.  Molecular characterization of Vibrio cholerae O1 strains circulating in Assam: a north eastern state of India.

Authors:  Ajanta Sharma; Bornali Sarmah Dutta; Debajit Rabha; Elmy Samsun Rasul; Naba Kumar Hazarika
Journal:  Iran J Microbiol       Date:  2021-10

10.  Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa.

Authors:  Marie Laure Quilici; Denis Massenet; Bouba Gake; Barem Bwalki; David M Olson
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.